Official SEC submissions

Polaryx Therapeutics SEC Filings

Direct answer

Polaryx Therapeutics's latest SEC filing is 8-K.

It was filed on September 14, 2026, and 15 recent filings are available.
Each row links directly to the SEC document and filing index.

Get free Polaryx Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Recent SEC filings

8-K

Current report

Filed:

Report date:

CURRENT REPORT

8-K

Current report

Filed:

Report date:

CURRENT REPORT

10-Q

Periodic report

Filed:

Report date:

QUARTERLY REPORT

DEFA14A

Proxy statement

Filed:

DEFINITIVE ADDITIONAL MATERIALS

DEF 14A

Proxy statement

Filed:

Report date:

PROXY STATEMENT

8-K

Current report

Filed:

Report date:

CURRENT REPORT

8-K

Current report

Filed:

Report date:

CURRENT REPORT

4

Insider transaction

Filed:

Report date:

8-K

Current report

Filed:

Report date:

CURRENT REPORT

10-Q

Periodic report

Filed:

Report date:

QUARTERLY REPORT

10-K

Periodic report

Filed:

Report date:

ANNUAL REPORT

4

Insider transaction

Filed:

Report date:

S-1/A

Registration statement

Filed:

REGISTRATION STATEMENT

S-1/A

Registration statement

Filed:

REGISTRATION STATEMENT

S-1

Registration statement

Filed:

REGISTRATION STATEMENT

Verified data

Recent filing categories
5
Recent filings
15
SEC CIK
0002075320
Latest filing date
September 14, 2026